Young Gil Ahn
Inventor
Stats
- 8 US patents issued
- 29 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 8 US Patents Issued
- 29 US Applications Filed
- 54 Total Citation Count
- Oct 20, 2022 Most Recent Filing
- Oct 6, 2004 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
HANMI PHARM. CO., LTD. | 1
2 2 | 2011
2012 2013 |
HANMI SCIENCE CO., LTD. | 2
1 7 2 | 2004
2009 2011 2014 |
CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION | 2
| 2011
|
KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY | 2
| 2011
|
KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY | 1
| 2013
|
Inventor Addresses
Address | Duration |
---|---|
Gyeonggi-do, KR | Mar 05, 15 - Mar 05, 15 |
Hwaseong-si, Gyeonggi-do, KR | Feb 29, 24 - Feb 29, 24 |
Hwaseong-si, KR | Jan 31, 19 - Dec 26, 24 |
Kyungki-do, KR | Mar 29, 07 - Mar 29, 07 |
Seongnam-si, KR | Dec 01, 09 - Jun 25, 19 |
Seoul, KR | Mar 02, 23 - May 30, 24 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 15 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 15 |
C07D: | HETEROCYCLIC COMPOUNDS | 25 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2024/0423,979 | 2024 | THERAPEUTICALLY EFFECTIVE COMBINATION OF A FLT3 INHIBITOR AND A BCL-2 INHIBITOR FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA | 0 |
2024/0173,329 | 2024 | BELVARAFENIB FOR USE IN TREATMENT OF BRAIN CANCERS | 0 |
2024/0067,613 | 2024 | NOVEL QUINAZOLINE DERIVATIVES AS SOS1 INHIBITORS AND USE THEREOF | 0 |
2023/0060,973 | 2023 | THIENO[3,2-D]PYRIMIDINE DERIVATIVE COMPOUND HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASE | 0 |
2023/0002,358 | 2023 | PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING CANCERS INCLUDING THE SAME | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.